MustGrow Biologics Corp. (OTCMKTS:MGROF – Get Free Report) saw a significant decrease in short interest in August. As of August 31st, there was short interest totaling 2,500 shares, a decrease of 88.5% from the August 15th total of 21,660 shares. Based on an average trading volume of 4,404 shares, the short-interest ratio is presently 0.6 days.
MustGrow Biologics Stock Performance
Shares of MGROF stock traded up C$0.02 during mid-day trading on Friday, reaching C$0.32. The company’s stock had a trading volume of 100 shares, compared to its average volume of 5,394. The company’s 50 day simple moving average is C$0.29 and its 200-day simple moving average is C$0.35. MustGrow Biologics has a 12-month low of C$0.22 and a 12-month high of C$0.68.
MustGrow Biologics Company Profile
MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets.
Featured Stories
- Five stocks we like better than MustGrow Biologics
- Oracle’s AI Spending Is Still Huge, But the Payoff Is Starting to Show in Earnings
- TSMC Revenue Jumps 53% in August, Signaling Strong AI Chip Demand
- This AI ETF Is Missing the Biggest AI Winners
- Could Snowflake’s Big Quarter Be a Sign of More to Come?
Receive News & Ratings for MustGrow Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MustGrow Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
